Current Health to invest in coordinating in-home staffing, services. Read the announcement.

Advanced therapies

Current Health Clinical Evidence Summary

We've proven safe, effective, and scalable outpatient delivery for advanced therapies.

Our Insights

For years, Current Health has collaborated with leading providers to publish real-world research on outpatient and community advanced therapy delivery.

Select a resource opposite to explore the evidence we’ve helped generate.

Proven at Scale

75% of CAR-T delivered outpatient

Sarah Cannon safely transitioned most CAR-T therapies to outpatient care, saving 1,200+ hospital bed days in the first 100 patients.

View the case study

Safety Confirmed

CRS/ICANS captured within 15 days

Multi-site analysis shows nearly all CRS/ICANS events occurred in the first two weeks, supporting shorter monitoring windows.

View the poster

Validated Outcomes

Bispecific step-up dosing safely delivered outpatient

89% of patients were able to successfully receive step-up doses of Teclistamab and talquetamab at MSK.

View the ASH abstract

Operational Framework

How to build outpatient CAR-T programs

JCO Oncology Practice review outlines SOPs, ED workflows, and clinical pathways for scalable outpatient delivery models.

View the abstract

Care at Home

How Current Health supports CAR-T patients

Current Health enables oncology therapies such as CAR-T, bispecifics, and BMT to be delivered safely in the home.

View the executive brief

Earlier Intervention

CRS detected ~3.4 hours earlier (205 minutes)

Continuous monitoring identified cytokine release syndrome sooner than standard care, enabling earlier treatment and intervention.

View the study

From evidence to impact.

Current Health provides the clinical and operational infrastructure for safe, scalable delivery of CAR-T, bispecifics, and other advanced therapies in community and home settings.

Our latest insights

Check out recent articles and resources.